Third Rock Ventures ^Investors

Third Rock Ventures is a leading healthcare venture firm that invests in transformational life science companies with high growth potential. They focus on advancing disruptive areas of science and medicine to deliver breakthroughs in the marketplace. The organization believes in the companies they start and provides significant initial investments, often supplemented by strategic collaborations, to help their firms progress in developing life-changing medicines, technologies, and diagnostics. Some of their notable achievements include the development of new generation medicines for cardiometabolic diseases, advancements in neuropsychiatry, precision medicine in immuno-oncology, and the approval of cell-based gene therapy for sickle cell disease.